varenicline has been researched along with Obesity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Heggen, E; Klemsdal, TO; Svendsen, M; Tonstad, S | 2 |
| Azrin, ST; Baller, J; Daumit, GL; Juliano-Bult, D; McGinty, EE | 1 |
| Abughosh, SM; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wu, IH; Yang, M | 1 |
| Achtyes, ED; Cather, C; Evins, AE; Hoeppner, SS; Pachas, GN; Pratt, S; Thorndike, AN | 1 |
| Choi, DS; Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RT; Schroeder, DR | 1 |
| Heggen, E; Svendsen, M; Tonstad, S | 1 |
| Bornstein, MM; Klingler, K; Ramseier, CA; Saxer, UP; Walter, C | 1 |
| Anthenelli, RM | 1 |
1 review(s) available for varenicline and Obesity
| Article | Year |
|---|---|
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine Uptake Inhibitors; Health Behavior; HIV Infections; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Metformin; Motor Activity; Nicotinic Agonists; Obesity; Overweight; Risk Reduction Behavior; Schizophrenia; Smoking; Smoking Cessation; Varenicline | 2016 |
5 trial(s) available for varenicline and Obesity
| Article | Year |
|---|---|
Diet, eating behaviour and weight gain in men and women with overweight/obesity receiving varenicline for smoking cessation.
Topics: Diet; Feeding Behavior; Female; Humans; Male; Obesity; Overweight; Smoking Cessation; Surveys and Questionnaires; Varenicline; Weight Gain | 2021 |
Low Carbohydrate and Moderately Fat-Reduced Diets Similarly Affected Early Weight Gain in Varenicline-Treated Overweight or Obese Smokers.
Topics: Adult; Aged; Diet, Carbohydrate-Restricted; Diet, Fat-Restricted; Female; Humans; Male; Middle Aged; Obesity; Overweight; Smokers; Smoking; Smoking Cessation; Varenicline; Weight Gain; Young Adult | 2016 |
Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypertension; Male; Mental Disorders; Middle Aged; Obesity; Remission Induction; Smoking Cessation; Varenicline; Weight Gain | 2016 |
Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.
Topics: Adult; Benzazepines; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Obesity; Overweight; Pilot Projects; Tobacco Use Disorder; Varenicline; Weight Gain; Young Adult | 2017 |
Smoking cessation improves cardiometabolic risk in overweight and obese subjects treated with varenicline and dietary counseling.
Topics: Adult; Biomarkers; Blood Pressure; Counseling; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Nicotinic Agonists; Norway; Obesity; Prevalence; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Treatment Outcome; Triglycerides; Varenicline; Weight Loss | 2017 |
3 other study(ies) available for varenicline and Obesity
| Article | Year |
|---|---|
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Nicotinic Agonists; Obesity; Proportional Hazards Models; Retrospective Studies; Risk; Smoking; Smoking Cessation; Varenicline; Young Adult | 2015 |
[Tobacco use prevention and cessation in the dental practice].
Topics: Behavior Therapy; Benzazepines; Bupropion; Dentist-Patient Relations; Health Plan Implementation; Humans; Interview, Psychological; Mouth Neoplasms; Nicotinic Agonists; Obesity; Periodontitis; Professional Role; Quinoxalines; Self Efficacy; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline; Weight Gain | 2007 |
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |